L'équipe du département de pharmacologie

DOMAINES

CONTACT

 

 

 

Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
fren

PUBLICATIONS 2017

Dernière mise à jour des publications: 2017-07-05

  1. Constituents and Antioxidant Activity of Bleeding Sap from Various Xinjiang Grapes
    Pharmacogn Mag. 2017 (13-51) 726-730
    Le L, Umar A, Iburaim A, Moore N.
     PubMed citation

  2. Comparison of treatment persistence with dabigatran or rivaroxaban versus vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a competing risk analysis in the French nationwide healthcare databases
    Pharmacotherapy. 2017 (ahead of print)
    Maura G, Billionnet C, Alla F, Gagne JJ, Pariente A.
     PubMed citation

  3. Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database
    Target Oncol. 2017 (ahead of print)
    Gouverneur A, Claraz P, Rousset M, Arnaud M, Fourrier-Réglat A, Pariente A, Aparicio T, Miremont-Salamé G, Noize P.
     PubMed citation

  4. Risk of motor vehicle accidents related to sleepiness at the wheel: a systematic review and meta-analysis
    Sleep. 2017 (ahead of print)
    Bioulac S, Micoulaud Franchi JA, Arnaud M, Sagaspe P, Moore N, Salvo F, Philip P.
     PubMed citation

  5. Definition of indicators of the appropriateness of oral anticoagulant prescriptions in hospitalized adults: Literature review and consensus (PACHA study)
    Arch Cardiovasc Dis. 2017 (ahead of print)
    Petit-Monéger A, Thiessard F, Noize P, Berdaï D, Jouhet V, Saillour-Glénisson F, Salmi LR; PACHA research group.
     PubMed citation

  6. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study
    Antiviral Res. 2017 (ahead of print)
    Rousseau A, Boutolleau D, Titier K, Bourcier T, Chiquet C, Weber M, Colin J, Gueudry J, M'Garrech M, Bodaghi B, Burrel S, Agut H, Deback C; HEDGOF (Herpes Eye Disease Group of France), Labetoulle M.
     PubMed citation

  7. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results
    J Hepatol. 2017 (ahead of print)
    Thabut D, Pauwels A, Carbonell N, Remy AJ, Nahon P, Causse X, Cervoni JP, Cadranel JF, Archambeaud I, Bramli S, Ehrhard F, Ah-Soune P, Rostain F, Pariente A, Vergniol J, Dupuychaffray JP, Pelletier AL, Skinazi F, Guillygomarc'h A, Vitte RL, Henrion J, Combet S, Rudler M, Bureau C; des Hépato-Gastroentérologues des Hôpitaux Généraux (ANGH).
     PubMed citation

  8. Atropinic (Anticholinergic) Burden in Antipsychotic-Treated Patients
    Fundam Clin Pharmacol. 2017 (ahead of print)
    Montastruc F, Benevent J, Touafchia A, Chebane L, Araujo M, Guitton-Bondon E, Durrieu G, Arbus C, Schmitt L, Begaud B, Montastruc JL.
     PubMed citation

  9. Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study
    Eur J Cancer. 2017 (85) 39-48
    Ravaud A, Gomez-Roca C, Picat MQ, Digue L, Chevreau C, Gimbert A, Chauzit E, Sitta R, Cornelis F, Asselineau J, Aziza R, Daste A, Quemener C, Baud J, Bikfalvi A, Pedenon-Périchout D, Doussau A, Molimard M, Delord JP.
     PubMed citation

  10. Medications recommended for secondary prevention after first acute coronary syndrome: Effectiveness of treatment combinations in real-life setting
    Clin Pharmacol Ther. 2017 (ahead of print)
    Bezin J, Klungel OH, Lassalle R, Dureau-Pournin C, Moore N, Pariente A.
     PubMed citation

  11. Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.
    Eur J Clin Pharmacol. 2017 (ahead of print)
    Pariente A, Mansiaux Y, Jarné A, Salvo F, Pageot C, Bezin J, Smith A, Bégaud B.
     PubMed citation

  12. Development and validation of hospital information system-generated indicators of the appropriateness of oral anticoagulant prescriptions in hospitalised adults: the PACHA study protocol
    BMJ Open. 2017 (7-8) e016488
    Petit-Monéger A, Thiessard F, Jouhet V, Noize P, Berdaï D, Kret M, Sitta R, Salmi LR, Saillour-Glénisson F; PACHA research group.
     PubMed citation

  13. Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review
    J Geriatr Oncol. 2017 (ahead of print)
    Gouverneur A, Salvo F, Berdaï D, Moore N, Fourrier-Réglat A, Noize P.
     PubMed citation

  14. Self-medication misuse in the Middle East: a systematic literature review
    Pharmacol Res Perspect. 2017
    Khalifeh MM, Moore ND, Salameh PR.
     PubMed citation

  15. National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study
    Pharmacoepidemiol Drug Saf. 2017 (ahead of print)
    Bosco-Lévy P, de Boissieu P, Gouverneur A, Noize P, Molimard M, Fourrier-Réglat A, Bezin J.
     PubMed citation

  16. Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France
    BMJ Open. 2017 (7-7) e015905
    Bénard-Laribière A, Pariente A, Pambrun E, Bégaud B, Fardet L, Noize P.
     PubMed citation

  17. Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study
    Pharmacoepidemiol Drug Saf. 2017 (ahead of print)
    Maura G, Pariente A, Alla F, Billionnet C.
     PubMed citation

  18. Management and 3-month outcomes of isolated superficial vein thrombosis of the lower limb: A real-world cohort study
    Thromb Res. 2017 (157) 117-119
    Blin P, Sevestre MA, Pouchain D, Gillet JL.
     PubMed citation

  19. Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma
    Clin Chim Acta. 2017 (ahead of print)
    Rousset M, Dutriaux C, Bosco-Lévy P, Prey S, Pham-Ledard A, Dousset L, Gérard E, Bouchet S, Canal-Raffin M, Titier K, Molimard M.
     PubMed citation

  20. Assessing drug causality: it is time to become European!
    Pharmacol Res. 2017 (ahead(of pviNt)
    Bégaud B.
     PubMed citation

  21. A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare products
    Br J Clin Pharmacol. 2017 (ahead of print)
    Bégaud B, Daemen E, Dokas I, Edwards B, Fishbein JM, Greenberg HE, Hochberg A, Le Louet H, Lyngvig J, Mogles N, Owen K, Prendergast C, Rejzek M, Trantza S, Webb D, Whalen M, Whiteley S.
     PubMed citation

  22. Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database
    Drug Saf. 2017 (ahead of print)
    Pageot C, Bezin J, Smith A, Arnaud M, Salvo F, Haramburu F, Bégaud B, Pariente A; French Network of Pharmacovigilance Centres.
     PubMed citation

  23. Road traffic crash risk associated with prescription of hydroxyzine and other sedating H1-antihistamines: A responsibility and case-crossover study
    Accid Anal Prev. 2017 (ahead of print)
    Orriols L, Luxcey A, Contrand B, Bénard-Laribière A, Pariente A, Gadegbeku B, Lagarde E.
     PubMed citation

  24. False-positive results in pharmacoepidemiology and pharmacovigilance
    Therapie. 2017 (ahead of print)
    Bezin J, Bosco-Levy P, Pariente A.
     PubMed citation

  25. Agreement between hospital discharge diagnosis codes and medical records to identify metastatic colorectal cancer and associated comorbidities in elderly patients
    Rev Epidemiol Sante Publique. 2017 (65-4) 321-325
    Gouverneur A, Dolatkhani D, Rouyer M, Grelaud A, Francis F, Gilleron V, Fourrier-Réglat A, Noize P.
     PubMed citation

  26. Trends in the incidence of use of non-insulin glucose-lowering drugs between 2006 and 2013 in France
    Fundam Clin Pharmacol. 2017 (ahead of print)
    Arnaud M, Bezin J, Bégaud B, Pariente A, Salvo F.
     PubMed citation

  27. Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study
    Pharmacoepidemiol Drug Saf. 2017 (ahead of print)
    Noize P, Grelaud A, Bay JO, Chevreau C, Gross-Goupil M, Culine S, Ferrière JM, Moulin F, Robinson P, Balestra A, Lamarque S, Bernard MA, Lassalle R, Rouyer M, Droz-Perroteau C, Moore N, Fourrier-Réglat A, Ravaud A.
     PubMed citation

  28. Drug Interaction With Sunitinib and the Evidence of Therapeutic Drug Monitoring: A Case Report and Review of the Literature
    Clin Genitourin Cancer. 2017 (ahead of print)
    Bertolaso P, Gross-Goupil M, Molimard M, Cochin V, Ravaud A, Daste A.
     PubMed citation

  29. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
    Pharmacoepidemiol Drug Saf. 2017 (ahead of print)
    Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, Moore N.
     PubMed citation

  30. Methods for safety signal detection in healthcare databases: a literature review
    Expert Opin Drug Saf. 2017 (16-6) 721-732
    Arnaud M, Bégaud B, Thurin N, Moore N, Pariente A, Salvo F.
     PubMed citation

  31. Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma
    Cancer Chemother Pharmacol. 2017 (79-6) 1273-1276
    Thiery-Vuillemin A, Orillard E, Mouillet G, Calcagno F, Devillard N, Bouchet S, Royer B.
     PubMed citation

  32. Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort
    BMC Med. 2017 (15-1) 81
    Carrière I, Norton J, Farré A, Wyart M, Tzourio C, Noize P, Pérès K, Fourrier-Réglat A, Ritchie K, Ancelin ML.
     PubMed citation

  33. An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients
    Clin Chim Acta. 2017 (ahead of print)
    Rousset M, Titier K, Bouchet S, Dutriaux C, Pham-Ledard A, Prey S, Canal-Raffin M, Molimard M.
     PubMed citation

  34. Potential Limitations of a very short course of antimicrobial therapy for VAP
    Clin Infect Dis. 2017 (ahead of print)
    Boyer A, Leffondre K, Laterrade T, Berdaï D, Gruson D.
     PubMed citation

  35. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network]
    Therapie. 2017 (ahead of print)
    Frauger E, Pochard L, Boucherie Q, Giocanti A, Chevallier C, Daveluy A, Gibaja V, Caous AS, Eiden C, Authier N, Le Boisselier R, Guerlais M, Jouanjus É, Lepelley M, Pizzoglio V, Pain S, Richard N, Micallef J; le Réseau français d’addictovigilance.
     PubMed citation

  36. Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-Based Multi-Database Study
    Clin Ther. 2017 (39-4) 759-770
    Overbeek JA, Heintjes EM, Prieto-Alhambra D, Blin P, Lassalle R, Hall GC, Lapi F, Bianchini E, Hammar N, Bezemer ID, Herings RM.
     PubMed citation

  37. Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study
    Acta Psychiatr Scand. 2017 (135-5) 429-438
    Verdoux H, Pambrun E, Tournier M, Bezin J, Pariente A.
     PubMed citation

  38. Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases
    Pharmacoepidemiol Drug Saf. 2017 (26-5) 535-543
    Billionnet C, Alla F, Bérigaud É, Pariente A, Maura G.
     PubMed citation

  39. Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs
    Clin Pharmacokinet. 2017 (ahead of print)
    Usmani OS, Molimard M, Gaur V, Gogtay J, Singh GJ, Malhotra G, Derom E.
     PubMed citation

  40. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
    Clin Transl Allergy. 2017 (Feb 20) 7-5
    Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PA, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicio?lu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Khaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N'Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GM, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.
     PubMed citation

  41. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017 (49-2) pii: 1601794
    Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A, Droz-Perroteau C, Lassalle R, Moore N, Girodet PO.
     PubMed citation

  42. [Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)]
    Ann Cardiol Angeiol (Paris). 2017 (ahead of print)
    Philippe F, Blin P, Bouée S, Laurendeau C, Torreton E, Gourmelin J, Velkovski-Rouyer M, Levy-Bachelot L, Steg G.
     PubMed citation

  43. Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.
    Pharmacoepidemiol Drug Saf. 2017 (26-3) 285-293
    Bezin J, Groenwold RH, Ali MS, Lassalle R, Robinson P, de Boer A, Moore N, Klungel OH, Pariente A.
     PubMed citation

  44. Risk of Myopathy Associated With DPP-4 Inhibitors in Combination With Statins: A Disproportionality Analysis Using Data From the WHO and French Spontaneous Reporting Databases.
    Diabetes Care. 2017 (40-3) e27-e29
    Labat V, Arnaud M, Miremont-Salamé G, Salvo F, Bégaud B, Pariente A.
     PubMed citation

  45. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study.
    Pharmacoepidemiol Drug Saf. 2017 (26-2) 162-169
    Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, Bégaud B, Pariente A.
     PubMed citation

  46. Late diagnosis of primary hyperoxaluria type III.
    Ann Clin Biochem. 2017 (54-3) 406-411
    Richard E, Blouin JM, Harambat J, Llanas B, Bouchet S, Acquaviva C, de la Faille R.
     PubMed citation

  47. An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders.
    Br J Clin Pharmacol. 2017 (83-3) 612-622
    Nguyen TT, Pariente A, Montastruc JL, Lapeyre-Mestre M, Rousseau V, Rascol O, Bégaud B, Montastruc F.
     PubMed citation

  48. How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital.
    Fundam Clin Pharmacol. 2017 (31-1) 104-109
    Gouverneur A, Rouyer M, Grelaud A, Robinson P, Colombani F, Terrebonne E, Smith D, Fourrier-Réglat A, Noize P.
     PubMed citation

  49. Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey.
    Fundam Clin Pharmacol. 2017 (31-1) 126-131
    Daveluy A, Frauger E, Peyrière H, Moracchini C, Haramburu F, Micallef J.
     PubMed citation

  50. Parachuting: a dangerous trend in recreational psychoactive substance delivery.
    Expert Opin Drug Deliv. 2017 (14-4) 491-498
    Boels D, Grall-Bronnec M, Guerlais M, Le Roux G, Spiers A, Gerardin M, Lomenech H, Bretaudeau-Deguigne M, Daveluy A, Turcant A, Jolliet P, Victorri-Vigneau C.
     PubMed citation

  51. Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies.
    Pharmacol Res. 2017 (118) 43-52
    Salvo F, Bezin J, Bosco-Levy P, Letinier L, Blin P, Pariente A, Moore N.
     PubMed citation

  52. Impact of a public media event on the use of statins in the French population.
    Arch Cardiovasc Dis. 2017 (110-2) 91-98
    Bezin J, Francis F, Nguyen NV, Robinson P, Blin P, Fourrier-Réglat A, Pariente A, Moore N.
     PubMed citation

  53. News from Tartary: an ethnopharmacological approach to drug and therapeutic discovery
    Br J Clin Pharmacol. 2017 (83-1) 33-37
    Moore N, Hamza N, Berke B, Umar A.
     PubMed citation